Risultati della ricerca - Ren‐Wang Peng
- Mostra 1 - 20 risultati su 20
-
1
-
2
Multiple SNARE interactions of an SM protein: Sed5p/Sly1p binding is dispensable for transport di Ren‐Wang Peng, Dieter Gallwitz
Pubblicazione 2004Artigo -
3
-
4
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness di Haitang Yang, Shun‐Qing Liang, Ralph A. Schmid, Ren‐Wang Peng
Pubblicazione 2019Revisão -
5
Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks di Ke Xu, Jie Ma, Sean R. R. Hall, Ren‐Wang Peng, Haitang Yang, Feng Yao
Pubblicazione 2023Revisão -
6
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT di Colin Charles Tièche, Ren‐Wang Peng, Patrick Dorn, Laurène Froment, Ralph A. Schmid, Thomas M. Marti
Pubblicazione 2016Artigo -
7
-
8
-
9
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma di Haitang Yang, Sean R. R. Hall, Beibei Sun, Liang Zhao, Yanyun Gao, Ralph A. Schmid, Swee T. Tan, Ren‐Wang Peng, Feng Yao
Pubblicazione 2021Artigo -
10
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer di Shun‐Qing Liang, Thomas M. Marti, Patrick Dorn, Laurène Froment, S. Hall, Sabina Berezowska, Gregor J. Kocher, Ralph A. Schmid, Ren‐Wang Peng
Pubblicazione 2015Artigo -
11
ACSL3–PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression di Matteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, Yang Zhang, Ren‐Wang Peng, Mirco Galiè, Kevin Oberson, Hans‐Uwe Simon, Eva Karamitopoulou, Georgia Konstantinidou
Pubblicazione 2020Artigo -
12
LDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage di Haibin Deng, Fatlind Malsiu, Huixiang Ge, Tereza Losmanová, Michaela Medová, Nicola Zamboni, Wenxiang Wang, Ren‐Wang Peng, Jinming Tang, Patrick Dorn, Thomas M. Marti
Pubblicazione 2025Artigo -
13
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer di Haitang Yang, Shun‐Qing Liang, Duo Xu, Yang Zhang, Thomas M. Marti, Yanyun Gao, Gregor J. Kocher, Heng Zhao, Ralph A. Schmid, Ren‐Wang Peng
Pubblicazione 2019Artigo -
14
Advancing cancer therapy: new frontiers in targeting DNA damage response di Jiekun Qian, Guoliang Liao, Maohui Chen, Ren‐Wang Peng, Yanfei Xin, Jianting Du, Renjie Huang, Maojie Pan, Yuxing Lin, Xian Gong, Guobing Xu, Bin Zheng, Chun Chen, Yang Zhang
Pubblicazione 2024Revisão -
15
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma di Tuo Zhang, Beibei Sun, Chenxi Zhong, Ke Xu, Zhexin Wang, Paul Hofman, Tatsuya Nagano, Antoine Legras, Daniel Breadner, Biagio Ricciuti, Duilio Divisi, Ralph A. Schmid, Ren‐Wang Peng, Haitang Yang, Feng Yao
Pubblicazione 2021Artigo -
16
Multi-scale integrative analyses identify THBS2<sup>+</sup> cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma di Haitang Yang, Beibei Sun, Liwen Fan, Wenyan Ma, Ke Xu, Sean R. R. Hall, Zhexin Wang, Ralph A. Schmid, Ren‐Wang Peng, Thomas M. Marti, Wen Gao, Jianlin Xu, Weiwei Yang, Feng Yao
Pubblicazione 2022Artigo -
17
Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer di Haibin Deng, Liang Zhao, Huixiang Ge, Yanyun Gao, Yan Fu, Ya‐Wen Lin, Mojgan Masoodi, Tereza Losmanová, Michaela Medová, Julien G. Ott, Min Su, Wenxiang Wang, Ren‐Wang Peng, Patrick Dorn, Thomas M. Marti
Pubblicazione 2025Artigo -
18
Transitional CXCL14<sup>+</sup> cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lun... di Weijiao Xu, Haitang Yang, Ke Xu, Anshun Zhu, Sean R. R. Hall, Yunxuan Jia, Baicheng Zhao, Enshuo Zhang, Gang Liu, Jianlin Xu, Thomas M. Marti, Ren‐Wang Peng, Patrick Dorn, Yongliang Niu, Xufeng Pan, Yajuan Zhang, Feng Yao
Pubblicazione 2025Artigo -
19
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 di Colin Charles Tièche, Yanyun Gao, Elias D. Bührer, Nina Hobi, Sabina Berezowska, Kurt Wyler, Laurène Froment, Stefan Weis, Ren‐Wang Peng, Rémy Bruggmann, Primo Schär, Michael A. Amrein, Sean Ralph Robert Hall, Patrick Dorn, Gregor J. Kocher, Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Thomas M. Marti
Pubblicazione 2018Artigo -
20
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damag... di Haibin Deng, Yanyun Gao, Verdiana Trappetti, Damian Hertig, Darya Karatkevich, Tereza Losmanová, Christian Urzì, Huixiang Ge, Gerrit Adriaan Geest, Rémy Bruggmann, Valentin Djonov, Jean‐Marc Nuoffer, Peter Vermathen, Nicola Zamboni, Carsten Riether, Adrian F. Ochsenbein, Ren‐Wang Peng, Gregor J. Kocher, Ralph A. Schmid, Patrick Dorn, Thomas M. Marti
Pubblicazione 2022Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Cancer research
Cancer
Genetics
Medicine
Gene
Internal medicine
Lung cancer
Biochemistry
Oncology
Cell biology
Chemistry
Cancer cell
Cell
Immunology
Metastasis
Bioinformatics
DNA
DNA damage
Epithelial–mesenchymal transition
KRAS
Molecular biology
Paleontology
Adenocarcinoma
Cancer stem cell
Cell cycle
Chemotherapy
Cisplatin
Colorectal cancer
DNA repair